Screening Power of Short Tau Inversion Recovery Muscle Magnetic Resonance Imaging in Critical Illness Myoneuropathy and Guillain-Barre Syndrome in the Intensive Care Unit
Overview
Authors
Affiliations
Introduction: Critical illness myoneuropathy (CIMN) or intensive care unit (ICU)-acquired weakness (AW) is a common cause of weakness in ICU patients. Guillain-Barre syndrome (GBS) is also a common cause of acute neurological weakness in the ICU. It is diagnosed by clinical features, nerve conduction studies (NCS), and muscle/nerve biopsies.
Methods: The short tau inversion recovery (STIR) muscle magnetic resonance (MR) images of seven patients with suspected CIMN and seven GBS patients over a 5-year period from February 2015 till May 2020 were analyzed.
Results: All seven patients with CIMN showed diffuse muscle edema, predominating in the lower limbs. Only one patient with GBS showed abnormal magnetic resonance imaging (MRI) changes (14%) and MRI was normal in 86%. The sensitivity of MRI to detect CIMN was 100%, whereas the specificity was 85.7%. Thus, the positive predictive value (PPV) of MRI in this situation was 87.5% and the negative predictive value (NPV) was 100%.
Conclusion: Muscle STIR imaging may help to differentiate between CIMN and GBS.
How To Cite This Article: Maramattom BV. Screening Power of Short Tau Inversion Recovery Muscle Magnetic Resonance Imaging in Critical Illness Myoneuropathy and Guillain-Barre Syndrome in the Intensive Care Unit. Indian J Crit Care Med 2022;26(2):204-209.
Potential diagnostic tools for intensive care unit acquired weakness: A systematic review.
Xin C, Gai Y, Wei L, Wang Y, Luo Y, Han B Int J Nurs Stud Adv. 2025; 8:100301.
PMID: 39995749 PMC: 11849193. DOI: 10.1016/j.ijnsa.2025.100301.
Early detection and assessment of intensive care unit-acquired weakness: a comprehensive review.
Elkalawy H, Sekhar P, Abosena W Acute Crit Care. 2023; 38(4):409-424.
PMID: 38052508 PMC: 10718497. DOI: 10.4266/acc.2023.00703.
Usefulness and Clinical Impact of Whole-Body MRI in Detecting Autoimmune Neuromuscular Disorders.
Pace M, Cannella R, Di Stefano V, Lupica A, Alonge P, Morici G Brain Sci. 2023; 13(10).
PMID: 37891867 PMC: 10605918. DOI: 10.3390/brainsci13101500.
Klawitter F, Walter U, Axer H, Patejdl R, Ehler J Medicina (Kaunas). 2023; 59(5).
PMID: 37241077 PMC: 10223702. DOI: 10.3390/medicina59050844.